NEW YORK, Nov. 22, 2016 /PRNewswire/ -- The global respiratory diagnostics market is projected to reach USD 7.45 billion by 2021 from USD 5.24 billion in 2016, at a CAGR of 7.3% from 2016 to 2021. Increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in respiratory diagnostic systems are the major factors driving the growth of the global respiratory diagnostics market.
Developing markets in Asia-Pacific such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore offer lucrative opportunities for players in the respiratory diagnostics market. Rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, and expansion of private-sector hospitals to rural areas in various APAC countries are the major factors driving the growth of the respiratory diagnostics market.
The global respiratory diagnostics market is broadly segmented by product and service, test type, disease, end user, and region. On the basis of product and service, the respiratory diagnostics market is segmented into instruments & devices, assays & reagents, and software & services. The instruments and devices segment is expected to account for the largest share of the respiratory diagnostics market in 2016. This large share can be attributed to the continuous requirement of diagnostic instruments and devices in laboratories, point-of-care, and home care diagnosis.
On the basis of test type, the respiratory diagnostics market is broadly classified into mechanical tests, imaging tests, traditional diagnostic tests, and molecular diagnostic tests. In 2016, the traditional diagnostic tests segment is expected to account for the largest share of the respiratory diagnostics market. The large share of this segment can be primarily attributed to the quick turnaround time of these tests. However, over the years, advancements in technology have led to the replacement of traditional techniques with molecular diagnostic techniques.
On the basis of disease, the respiratory diagnostics market is segmented into asthma, chronic obstructive pulmonary disease, lung cancer, tuberculosis, and other diseases. The tuberculosis segment is expected to account for the largest share of the respiratory diagnostics market in 2016. The large share of this segment can be primarily attributed to the increase in tobacco smoking and growing air pollution levels.
On the basis of end user, the respiratory diagnostics market is categorized into hospital/clinical laboratories, reference laboratories, physician offices, and other end users (including blood banks, point-of-care testing, patient self-testing, home health agencies, nursing homes, and local public health laboratories). In 2016, the hospital/clinical laboratories segment is expected to account for the largest share of the global respiratory diagnostics market. Most respiratory disease diagnostics are carried out in hospitals as they are complex in nature and require technologically advanced products; this is driving the respiratory diagnostics market for hospital/clinical laboratories. Point-of-care diagnostics and patient self-testing are also expected to contribute to the growth of the respiratory diagnostics market in the forecast period due to the increasing demand for convenient testing processes and quick results.
New and innovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.
From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the respiratory diagnostics market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the respiratory diagnostics market; high-growth regions; and market drivers, restraints, and opportunities.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on products offered by the top players in the respiratory diagnostics market
- Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the respiratory diagnostics market
- Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for respiratory diagnostics products across various regions
- Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the respiratory diagnostics market
- Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the respiratory diagnostics market
Read the full report: http://www.reportlinker.com/p04364966-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001
For more information:
Last updated on: 24/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.